Detalhe da pesquisa
1.
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.
N Engl J Med
; 379(9): 846-855, 2018 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30157388
2.
Validation of a new strength measurement device for amyotrophic lateral sclerosis clinical trials.
Muscle Nerve
; 45(1): 81-5, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22190312
3.
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical Trial.
J Clin Med
; 9(11)2020 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33207828
4.
Seven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical Trials.
JAMA Neurol
; 77(6): 755-763, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32202612
5.
Early molecular oxidative stress biomarkers of ischemic penumbra in acute stroke.
Neurology
; 93(13): e1288-e1298, 2019 09 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31455665
6.
Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis.
Contemp Clin Trials
; 50: 166-77, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27521810